Medicare Enrolled
Julie Kurek
Neurology · Augusta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Kurek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Kurek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Kurek
Julie Kurek is a neurology specialist in Augusta, GA, with 16 years of NPI registration. Based on federal Medicare data, Kurek performed 744 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Kurek received a total of $23,639 from 60 pharmaceutical and/or device companies across 541 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Kurek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 35% volume in GA
$23,639 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗744
Medicare services
Top 35% in GA for neurology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
268 | $103 | $246 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 87 | $14 | $76 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
64 | $105 | $229 |
| Brain stimulator programming, additional 15 minutes Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service. |
62 | $33 | $110 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
60 | $23 | $71 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
57 | $36 | $126 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
33 | $118 | $529 |
| Electronic analysis of implanted neurostimulator Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device. |
32 | $14 | $149 |
| Chemical paralysis of salivary glands, bilateral Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth. |
28 | $79 | $261 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $62 | $172 |
| New patient office visit, complex (60-74 min) | 26 | $128 | $368 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$23,639
Total received (2018-2024)
Avg $3,377/year across 7 years
Top 14% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
541
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,660
2023
$1,841
2022
$3,401
2021
$1,632
2020
$1,196
2019
$10,144
2018
$3,767
Payments by company (2024)
ABBVIE INC.
$514
Teva Pharmaceuticals USA, Inc.
$176
Boston Scientific Corporation
$166
Alexion Pharmaceuticals, Inc.
$106
ARGENX US, INC.
$90
Neurocrine Biosciences, Inc.
$81
AstraZeneca Pharmaceuticals LP
$69
Ipsen Biopharmaceuticals, Inc
$52
PFIZER INC.
$48
ACADIA Pharmaceuticals Inc
$40
Lundbeck LLC
$32
Amneal Pharmaceuticals LLC
$30
SK Life Science, Inc.
$28
Kyowa Kirin, Inc.
$27
Merz Pharmaceuticals, LLC
$27
Averitas Pharma Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$25
REVANCE THERAPEUTICS, INC.
$24
Otsuka America Pharmaceutical, Inc.
$23
Amicus Therapeutics, Inc.
$22
Kedrion Biopharma, Inc.
$21
Lilly USA, LLC
$16
Octapharma USA, Inc.
$14
Top 3 companies account for 51.5% of 2024 payments
All-time payments by company (2018-2024) ›
US WorldMeds, LLC
$7,554
Medtronic USA, Inc.
$2,559
Neurocrine Biosciences, Inc.
$2,227
Boston Scientific Corporation
$1,580
ABBVIE INC.
$1,280
Teva Pharmaceuticals USA, Inc.
$1,077
Abbott Laboratories
$924
MDD US Operations, LLC
$702
Allergan Inc.
$417
ACADIA Pharmaceuticals Inc
$400
Sunovion Pharmaceuticals Inc.
$362
Lundbeck LLC
$286
Adamas Pharmaceuticals, Inc.
$271
Alexion Pharmaceuticals, Inc.
$262
ARGENX US, INC.
$252
Amneal Pharmaceuticals LLC
$241
Ipsen Biopharmaceuticals, Inc
$232
MITSUBISHI TANABE PHARMA AMERICA, INC.
$225
Allergan, Inc.
$206
Merz Pharmaceuticals, LLC
$197
Amgen Inc.
$188
Avanir Pharmaceuticals, Inc.
$187
Eisai Inc.
$185
AbbVie Inc.
$159
EISAI INC.
$138
Avion Pharmaceuticals
$137
PFIZER INC.
$97
Otsuka America Pharmaceutical, Inc.
$92
Medtronic, Inc.
$87
Kyowa Kirin, Inc.
$83
UCB, Inc.
$82
Saol Therapeutics Inc.
$79
AstraZeneca Pharmaceuticals LP
$69
Takeda Pharmaceuticals U.S.A., Inc.
$67
JAZZ PHARMACEUTICALS INC.
$63
SK Life Science, Inc.
$59
AbbVie, Inc.
$56
Amylyx Pharmaceuticals, Inc.
$54
Biohaven Pharmaceutical Holding Company Ltd.
$50
Biogen, Inc.
$50
Acorda Therapeutics, Inc
$38
Impax Laboratories, Inc.
$36
Neurelis, Inc.
$31
Averitas Pharma Inc.
$27
REVANCE THERAPEUTICS, INC.
$24
Amicus Therapeutics, Inc.
$22
HOSPIRA, INC.
$22
Kedrion Biopharma, Inc.
$21
Scilex Pharmaceuticals Inc.
$21
GE Healthcare
$19
Baxter Healthcare
$17
E.R. Squibb & Sons, L.L.C.
$17
Lilly USA, LLC
$16
ARBOR PHARMACEUTICALS, INC.
$14
CSL Behring
$14
Octapharma USA, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
Merz North America, Inc.
$13
GENZYME CORPORATION
$12
NATUS MEDICAL INCORPORATED
$11
Top 3 companies account for 52.2% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AJOVY · AMYVID · APOKYN · APTIOM · AUSTEDO · Aimovig · Albuked · Austedo XR · BOTOX · BOTOX THERAPEUTIC · DAXXIFY · DUOPA · DYSPORT · Deep Brain Stimulation · Dhivy · Duopa · Dysport · ELIQUIS · EPIDIOLEX · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL - DBS · GENERAL DBS · GOCOVRI · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · IPX203 · Infinity DBS Pulse Generators · KYNMOBI · LATUDA · Leqembi · Lioresal (baclofen) · MYOBLOC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · Ongentys · PANZYGA · POMPE - DISEASE · Pombiliti · QULIPTA · QUTENZA · RADICAVA · RELYVRIO · REXULTI · RYTARY · SOLIRIS · SPINRAZA · SenSight · Skyclarys · UBRELVY · ULTOMIRIS · VALTOCO · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · XARELTO · XEOMIN · Xadago · Xeomin
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
83
County median income
$53,197
Nearest hospital to ZIP centroid (approximate)
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Kurek is a clinical cardiology specialist, with moderate Medicare volume, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Kurek experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Kurek performed 268 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Kurek receive payments from pharmaceutical companies?
Yes. Kurek received a total of $23,639 from 60 companies across 541 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Kurek's costs compare to other neurologists in Augusta?
Kurek's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Kurek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Augusta
Browse neurologists in Augusta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
US WorldMeds, LLC Payments to Doctors
See all physicians who received payments from US WorldMeds, LLC.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology